BioSpace News Archive

Specialised Therapeutics receives exclusive license to commercialize rigosertib in Australia and New Zealand Onconova to be eligible to receive up to US $30.4 million in clinical, regulatory, and sales-based milestones and tiered double-digit royalties

Independent pharmaceutical company Specialised Therapeutics Asia (STA) has signed an exclusive license deal with US-based Onconova Therapeutics (NASDAQ: ONTX), securing commercialisation rights to a new therapy for the treatment of Myelodysplastic Syndrome (MDS

New perspective piece gives physicians, patients guidelines on getting the best result

The Institute of Hematology & Blood Diseases Hospital (IHBDH), a clinical and research institute of the Chinese Academy of Medical Sciences and Peking Union Medical College, and Analysis Group, a global leader in health economics and outcomes research (HEOR), epidemiology, and real-world evidence (RWE), convened an advisory board at the American Society of Hematology (ASH) annual meeting

Award for Excellence in Human Research Protection for 2019 was announced by Dr. Peter G. Goldschmidt, President and Founder of Health Improvement Institute.

The replay of the webcast will be archived on the Company’s website for 30 days following the conference.

According to the Center for Disease Control (2017), 3 million seniors are treated in emergency departments for fall injuries each year and over 800,000 patients will be hospitalized due to head and hip injuries.

Many American physicians are wondering whether they still can be physicians. “We physicians have lost control of our profession, our patients’ safety, and our ability to freely practice patient-centered Hippocratic medicine in the United States,” writes San Antonio ophthalmologist Kristin Held, M.D., in the winter issue of the Journal of American Physicians and Surgeons.

From an outbreak of mysterious lung-injury deaths to America’s near loss of measles elimination status, the beginning of the end of the U.S. HIV epidemic to the Ebola outbreak in the Democratic Republic of the Congo, CDC worked around the clock – and around the globe – to protect Americans from domestic and global health threats in 2019.

Transgene (Paris:TNG) (Euronext Paris: TNG) today announced its financial reporting dates for 2020